Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03620175 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants
A Phase 1 study of Wound Healing, sponsored by BioMendics.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03620175 is a Phase 1 study of Wound Healing that has completed, run by BioMendics. The registered enrollment target is 22 participants, below the 56-participant average among 11 other Wound Healing trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03620175, a Phase 1 study of Wound Healing, has completed, sponsored by BioMendics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
TolaSure is a topical gel for the promotion of wound healing. This phase I study will assess the safety, tolerability and clinical effect of TolaSure when applied to skin wounds created by punch biopsy in healthy participants. A total of 26 healthy volunteers, males and females ages 18 years or older, will be enrolled. Subjects will monitored for safety and efficacy over the course of 2 weeks following daily topical administration of TolaSure.
Conditions Studied
Interventions
- DRUG TolaSure Topical Gel
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2018-07-16 |
| Est. Completion | 2018-12-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03620175
The ClinicalTrials.gov registry entry for NCT03620175 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 56-participant average among 11 other Wound Healing trials with a reported enrollment target (61% lower). The listed sponsor is BioMendics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Wound Healing appearing as the primary indexed condition, and to 1 intervention - of which TolaSure Topical Gel is the first listed.
NCT03620175 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03620175 about?
NCT03620175 is a clinical study titled "Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants". TolaSure is a topical gel for the promotion of wound healing. This phase I study will assess the safety, tolerability and clinical effect of TolaSure when applied to skin wounds created by punch biopsy in healthy participants. A total of 26 healthy volunteers, males and females ages 18 years or olde...
What is the current status of trial NCT03620175?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2018-07-16. Estimated completion is 2018-12-12.
What conditions does trial NCT03620175 study?
This clinical trial studies the following conditions: Wound Healing.
What interventions are being tested in trial NCT03620175?
The interventions under investigation include: TolaSure Topical Gel (DRUG).
Who is sponsoring clinical trial NCT03620175?
This trial is sponsored by BioMendics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03620175 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Wound Healing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Topical 0.5% Timolol Solution for Healing Lower Extremity Wounds
RECRUITING · Phase 1
-
Silk Bioprotein as a Wound Dressing for Double-Incision Mastectomy
RECRUITING · NA
-
Determinants of Bone Dimensional Changes After Extraction and Alveolar Ridge Preservation
RECRUITING
-
Evaluating rhPDGF-BB-Enhanced Wound Matrix for Head and Neck Reconstruction
RECRUITING · Phase 2
-
Dose Regimen Study of SLI-F06 in Healthy Volunteers
RECRUITING · Phase 2
-
Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.